One Chicago woman gave birth to twins 10 weeks prematurely, and the children needed extensive care. The medical bills topped out at around $80,000. Desperate, the parents loaded up credit cards, borrowed from relatives, and delayed repaying student loans.
People talk about the sacrifices they made when health care forced them into debt.
The U.S. health system now produces debt on a mass scale, a new investigation shows. Patients face gut-wrenching sacrifices.
Today, debt from medical and dental bills touches nearly every corner of American society.
Noble Health swept into two small Missouri towns promising to save their hospitals. Instead, workers and vendors say it stopped paying bills and government inspectors found it put patients at risk. Within two years — after taking millions in federal covid relief and big administrative fees — it locked the doors.
Under the Affordable Care Act, insurers cannot charge consumers for various preventive services that have been recommended by experts. But if those screenings indicate more testing is needed to determine whether something is wrong, patients may be on the hook for hundreds or even thousands of dollars for diagnostic services.
The U.S. House passed a package of bills seeking to keep some guns out of the hands of children and teenagers, but its fate in the Senate remains a big question mark. Meanwhile, the Federal Trade Commission takes on drug and hospital prices. Alice Miranda Ollstein of Politico, Anna Edney of Bloomberg News, and Joanne Kenen of the Johns Hopkins Bloomberg School of Public Health and Politico join KHN’s Julie Rovner to discuss these issues and more. Also this week, Rovner interviews Cori Uccello of the American Academy of Actuaries about the most recent report from Medicare’s trustees board.
In July, credit reporting bureaus will start taking paid medical debt off people’s credit reports. Here’s what you need to know.
Despite a consensus that patients should be able to get mental health care from primary care doctors, insurance policies and financial incentives may not support that.
Gov. Gavin Newsom proposed spending $100 million to make insulin affordable to millions of people with diabetes under a new state generic drug label, CalRx. But state officials haven’t said how much the insulin will cost patients or how the state will deal with distribution and other challenges.
